Paradigm Oral Health adds surgeons to executive team and board

Paradigm Oral Health promoted two surgeon partners to senior leadership and added two surgeons to its board after a surgeon-led buyback returned control of the company to its doctors. The moves deepen surgeon control over strategy, operations and governance as the oral surgery group continues to expand nationally.

Why it matters: - Paradigm Oral Health is concentrating clinical, growth and governance power in the hands of board-certified oral and maxillofacial surgeons. - The structure links ownership, management and board control inside one surgeon-led model. - Paradigm says the setup gives surgeons a clearer path from residency to practice ownership to executive leadership.

What happened: - Paradigm promoted Dr. Blake Ballenger to Chief Clinical Officer and Dr. Rian Cho to Chief Growth Officer. - Dr. Daniel Yacoob remains Chief Operating Officer. - Dr. David Rallis, founder and CEO, said four board-certified oral and maxillofacial surgeons now hold the company’s most senior executive roles. - Paradigm also added Dr. Tom Dietrich and Dr. Daniel Jeong to its surgeon-controlled Board of Directors. - The announcements came weeks after Paradigm completed a surgeon-led buyback that returned controlling ownership to surgeons and leadership. - Paradigm described the buyback as the third successful liquidity event for its doctors in seven years.

The details: - Dr. Ballenger will lead surgeon education and development from onboarding through advanced training. - Dr. Ballenger will also oversee clinical quality and workflow standards across Paradigm’s national portfolio. - Dr. Ballenger leads clinical programming at the Paradigm Innovation Institute, or Pi2. - Dr. Ballenger is based in Colorado. - Dr. Cho will oversee organic growth, including site selection, practice opening and ramp-up. - Dr. Cho will also help recruit and develop the next generation of Paradigm surgeons. - Dr. Cho is based in North Carolina. - Dr. Dietrich said governance makes surgeon ownership durable and helps ensure doctor-earned control shapes real decisions. - Dr. Jeong said the board and executive structure is designed to turn the ownership change into a long-term model for surgeons and patients.

Between the lines: - The appointments show Paradigm is using internal promotions, not outside hires, to fill top roles. - The company is signaling that surgeon leadership is part of its operating identity, not just a branding message. - The board additions extend surgeon control beyond equity and into long-term strategy. - The model may also help recruiting by showing a direct career path from clinical practice to enterprise leadership.

What's next: - Paradigm plans to keep growing through a surgeon-led model that develops new practices and new leaders from within. - The company intends to repeat the career arc of surgeon ownership, practice building and executive advancement as it expands. - Dr. Rallis said the new leaders will help shape Paradigm’s next chapter.

The bottom line: - Paradigm is putting surgeons in charge of the company’s operations, growth and governance at the same time.